Analysts lifted target prices on several names today. Three stand out for different reasons.
XYZ (Block, Inc.) saw its consensus target nudge up to $90.08. The fintech firm's $39 billion market cap and low short interest of 3.9% of free float suggest the street is broadly bullish. Block has been rebuilding investor confidence after a tough 2024.
ZBRA (Zebra Technologies) drew multiple analyst changes simultaneously. The consensus target edged up to $326.24. Zebra makes barcode scanners and mobile computing gear for warehouses. With tariff uncertainty easing slightly on supply chains, industrial tech names like Zebra are getting a second look. Short interest sits at 6.7% of free float — modest but worth watching.
LLY (Eli Lilly) received a fresh target raise to $1,210. That implies a market cap already above $862 billion. Lilly's GLP-1 franchise remains the engine. Analysts see continued demand for Mounjaro and Zepbound driving growth well into 2027.
EXPE (Expedia) was the only notable downward target move, slipping to $285.42 from $286.33. The cut is small but signals some caution on travel spending ahead.
STE (STERIS) also saw a target cut, dropping to $271.86 from $279.29 — a steeper 2.7% reduction in the healthcare equipment space.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
